These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36982896)

  • 21. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis.
    Mahdi ZM; Synal-Hermanns U; Yoker A; Locher KP; Stieger B
    Mol Pharmacol; 2016 Jul; 90(1):23-34. PubMed ID: 27112167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
    Stieger B
    Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid flopping in the liver.
    Linton KJ
    Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.
    Garzel B; Zhang L; Huang SM; Wang H
    Curr Drug Metab; 2019; 20(8):621-632. PubMed ID: 31288715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
    Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
    Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bile formation and cholestasis].
    Jansen PL; Müller M; Kuipers F
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2384-91. PubMed ID: 11145092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
    Lam P; Soroka CJ; Boyer JL
    Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
    Morita SY; Terada T
    Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular overview of progressive familial intrahepatic cholestasis.
    Amirneni S; Haep N; Gad MA; Soto-Gutierrez A; Squires JE; Florentino RM
    World J Gastroenterol; 2020 Dec; 26(47):7470-7484. PubMed ID: 33384548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver.
    Meier Y; Pauli-Magnus C; Zanger UM; Klein K; Schaeffeler E; Nussler AK; Nussler N; Eichelbaum M; Meier PJ; Stieger B
    Hepatology; 2006 Jul; 44(1):62-74. PubMed ID: 16799996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bile salt export pump: molecular properties, function and regulation.
    Arrese M; Ananthanarayanan M
    Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G670-6. PubMed ID: 24481602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.
    Yoshikado T; Takada T; Yamamoto T; Yamaji H; Ito K; Santa T; Yokota H; Yatomi Y; Yoshida H; Goto J; Tsuji S; Suzuki H
    Mol Pharmacol; 2011 Feb; 79(2):241-50. PubMed ID: 21056966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.